Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Advanced Nanotherapies Inc. currently faces 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are split between 2 distinct examiners, requiring the company to manage two separate prosecution tracks simultaneously. The portfolio's current activity is confined to 1 distinct art unit, suggesting a focused technical scope for the company's current medical device applications.
Tagwa Mohammad Abu-Dayeh is the busiest examiner for the company, managing 1 pending office action. The concentration of 2 pending office actions within 1 distinct art unit indicates that while multiple examiners are involved, they likely share a common technical background. This allows for a consistent technical message across the 2 pending matters despite the involvement of 2 distinct examiners.
For practitioners, the 2 pending office actions represent 2 distinct interactions within a single art unit. While the 2 distinct examiners may have different approaches to the 2 pending matters, the shared art unit provides a common framework for legal and technical arguments. Success requires a strategy that addresses the specific concerns of both examiners while maintaining a consistent position within the 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABU-DAYEH, TAGWA MOHAMMAD | 1 | — | — |
| STIGELL, THEODORE J | 1 | 78.3% | +14.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18729706 | Profiled Drug-Coated Balloons Using Nanoparticles and Methods of Drug Delivery Therewith | ABU-DAYEH, TAGWA MOHAMMAD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17908479 | Undulating Balloon Systems and Methods for Nanoparticle-Based Drug Delivery | STIGELL, THEODORE J | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18729706 | Profiled Drug-Coated Balloons Using Nanoparticles and Methods of Drug Delivery Therewith | ABU-DAYEH, TAGWA MOHAMMAD | 3783 | §103§112 | Non-Final OA | — | Pending | Jul 17, 2024 |
| 17908479 | Undulating Balloon Systems and Methods for Nanoparticle-Based Drug Delivery | STIGELL, THEODORE J | 3783 | §103 | Final Rejection | — | Pending | Aug 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAdvanced Nanotherapies Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Tagwa Mohammad Abu-Dayeh has the most, with 1 of Advanced Nanotherapies Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
